Innodem Neurosciences
PrivateLast Round
Series A
Jan 19, 2021
Total Funding Raised
$6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Innodem Neurosciences is a digital health and AI company that develops eye-tracking technology for the assessment and monitoring of neurodegenerative and mental diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innodem Neurosciences Comparables
Compare Innodem Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViewMind Inc. | 85% | |
| NeuraLight | 84% | |
| Saccadous, Inc. | 84% |
Innodem Neurosciences Funding Rounds
Historical fundraising activity
Innodem Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 53% MoM.
- Aug 21, 2026
Monthly visitors grew 197% MoM to 1.8K.
Innodem Neurosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Innodem Neurosciences's valuation, stock price, and market status.
Is Innodem Neurosciences a public or private company?
Innodem Neurosciences is a private company.
What is the current stock price of Innodem Neurosciences?
Innodem Neurosciences is a private company, so its shares have no public market price. Caplight tracks Innodem Neurosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innodem Neurosciences worth (valuation)?
Valuation information for Innodem Neurosciences is not publicly available.
Can I buy Innodem Neurosciences stock?
Innodem Neurosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innodem Neurosciences's last funding round?
Innodem Neurosciences's most recent funding round was Series A on January 19, 2021.
Who are the main investors in Innodem Neurosciences?
Key investors in Innodem Neurosciences include Morningside Group.
Will Innodem Neurosciences IPO soon?
No public IPO plans have been announced for Innodem Neurosciences.
How can I track Innodem Neurosciences secondary market activity?
Caplight tracks bids, offers, and trades in Innodem Neurosciences's shares on secondary markets.